We Understand Your Business

The healthcare and life sciences industry is simultaneously a new frontier and the backdrop for the daily lives and well-being of millions of people. Industry players deal with an ever-evolving slate of issues as they work toward the ultimate goal to improve peoples' lives, such as:

  • The COVID-19 pandemic has affected the industry in a number of ways, including establishing new collaborations with providers, suppliers and non-healthcare companies to make sure that organizations have the resources, equipment, infrastructure, capacity and data to meet the needs of patients and employees. Healthcare companies who can build on this spirit of cooperation and innovation to solve problems, create new supply chain models, improve patient consumerization and personalization, and continue to broaden telemedicine and digital care offerings will have the advantage.
  • As consumers demand cutting-edge technology that makes their care options more comprehensive, efficient and easier to understand, many healthcare companies are making it a priority to deliver ever-improving digital health choices that provide seamless collaboration between patients and their providers while making the necessary investments in data and IT infrastructure. Also key will be creative business strategies that increase collaboration with academic and research counterparts.
  • Fast-developing artificial intelligence, data analytics and other technological breakthroughs are being used to accelerate the drug development and manufacturing processes, streamline supply chains, improve the quality and efficiency of radiology, and widen the scope of predictive medicine.
  • The healthcare and life sciences industry overall is seeing an increase in private investment capital and a resurgence in merger and acquisition (M&A) activity and consolidation, but expect government regulators to more closely scrutinize such deals and combinations, on both horizontal and vertical levels, as larger health systems continue to emerge. The M&A, joint venture and partnership trend should continue as companies look for new revenue streams.

Is your company positioned to succeed?

We Can Help

With nearly 100 years of combined experience in the industry, members of our Healthcare & Life Sciences Team are on the leading edge of industry developments, and we can help you adapt your business strategy to effectively seize opportunities while avoiding risks. We represent the full range of healthcare-related businesses, including all providers along the care continuum, managed care organizations, health plans, third party administrators, provider networks, integrated delivery systems, management services organizations, managed care companies, manufacturers, healthcare technology companies, distributors, suppliers, pharmacies, pharmaceutical companies, medical device companies, biotechnology firms, venture capital firms and private equity firms, in all aspects of their regulatory issues and business operations, including:

  • Corporate Services: Our team has extensive experience handling healthcare transactions and can assist you with business planning and structuring, contracts and agreements, mergers and acquisitions and tax planning, all with an aim toward helping you operate more effectively and efficiently.
  • Data Privacy and Security: It is critical for healthcare and life science companies to effectively manage data privacy and security matters and comply with the growing number of related regulations, best practices and regulatory guidance. We can provide you with highly experienced technical and legal counsel on a wide array of issues, from de-identifying clinical trial data sets and patient information, managing mobile and Bring Your Own devices, working with mobile apps and network-aware medical devices, and complying with HIPAA and HITECH, to handling website data collection, use and sharing. We can also help prevent or deal with data and security breaches, assist you in responding to government investigations and provide guidance on international data transfer compliance.
  • Financial Services: Healthcare and life sciences operations require significant financial capital and our team can help you secure the necessary funding to achieve your business objectives, whether you are just getting started or are expanding your business.
  • Insurance: With the prevalence of liability issues confronting the healthcare and life sciences industry, we can help you anticipate risks and protect your interests through effective insurance planning.
  • Intellectual Property: In the highly competitive world of life sciences, protecting your intellectual property is critical to your success. Members of our team can help you safeguard your innovations by prosecuting patents; maintaining your portfolio; registering, protecting and litigating your patents and negotiating licensing agreements.
  • International: Our team can help you capitalize on the expanding global market by helping you address international trade compliance issues related to your medical devices and products.
  • Labor, Employment and Benefits: We can assist you in managing your company's most valuable asset - your human capital - by guiding you through common employment issues such as policies, training and benefits as well as issues that are critical to the healthcare and life sciences industry such as the safeguarding of trade secrets and enforcement of non-competes.
  • Litigation and Dispute Resolution: Disputes are a common occurrence within the healthcare and life sciences industry and, when a dispute arises, our team will quickly respond to defend your interests and seek the most desirable outcome possible so you can get back to business.
  • Nonprofit and Tax-Exempt Organizations: If you are a healthcare provider or research organization that is structured as a nonprofit entity, we can help you safely navigate the evolving rules and regulations that govern tax-exempt organizations.
  • Public Policy & Regulation: While public policy related to healthcare and life sciences is often contentious and always evolving, our team has a thorough understanding of legislative and regulatory proceedings and can help you advance your interests. In addition, we can provide you with regulatory counseling, including early guidance and advice, so you can achieve and maintain compliance with healthcare regulations such as HIPAA, HITECH and the Affordable Care Act.
  • Real Estate: We can assist you with the unique issues that accompany the acquisition, development, structuring, leasing, financing and disposition of properties that are used in connection with healthcare and biotechnology operations.
  • White Collar Defense and Investigations: Participants in the healthcare industry face increased risk and potentially devastating consequences arising from allegations of fraud and abuse. We can help you protect your interests by advising you on compliance with federal fraud and abuse statutes – including the False Claims Act, the Anti-Kickback statute, the Stark Self-Referral Rules and safe harbors. In the event of an allegation, we can defend your interests in enforcement actions as well as investigations by the U.S. Department of Health and Human Services Office of Inspector General and the U.S. Department of Justice.

Guidance You Can Trust

The combination of our thorough knowledge, our extensive experience and our sincere commitment to provide responsive service is why clients entrust our Healthcare & Life Sciences Team to handle their legal needs.

These attributes are also the reason why members of our team have been recognized among the top legal professionals in the country by leading publications, including Chambers USA – America's Leading Lawyers for Business, Best Lawyers in America and Florida Trend Magazine - Legal Elite. These publications base their rankings and commentary on input provided by those who are best positioned to evaluate our capabilities - our clients and other attorneys in the industry.

Recent honors earned by our team include:

  • Partner Maria Currier was named Law360 "MVP of the Year" in Health Care for 2022.
  • Holland & Knight received national first-tier rankings in the 2022 U.S. News – Best Lawyers® "Best Law Firms" guide in Health Care Law, and metropolitan first-tier rankings in the following markets: Dallas, Miami and Tallahassee. Partners Maria Currier, Jeff Mittleman, Shannon Hartsfield, Jerome Hoffman, Roberto Pupo, Jennifer Rangel and Michael Werner also have received Best Lawyers recognition.
  • The 2022 Chambers USA guide ranked Holland & Knight partners from New York, Florida, Texas, Massachusetts, and California for Healthcare law. The Firm ranked in Band 1 for Nationwide, Band 2 for Florida, Band 3 for Massachusetts, Band 3 for New York, and Band 4 for Texas.
  • The Legal 500 United States 2022 guide ranked Holland & Knight as a Tier 4 firm for Healthcare: Service Providers and as a "Firm to Watch" in Healthcare: Health Insurers.
  • Healthcare & Life Sciences member Jerome Hoffman was selected for Florida Trend's Florida Legal Elite 2021 Hall of Fame, and Maria Currier was recognized in Health law.
  • Healthcare & Life Sciences Industry Sector Group members Jeff Mittleman, Robert Hill and Ivan Colao were named among the 2020 Client Service All-Stars by the BTI Consulting Group.
  • Healthcare & Life Sciences Industry Sector Group Co-Chair Michael Werner was named to the National Law Journal’s list of Healthcare/Life Sciences Law Trailblazers
  • Holland & Knight received top recognition in the American Bar Association's Health Law Section - Annual Top 10 Law Firms in the Northeast, DC and Southeast rankings.
  • Holland & Knight has been ranked among the top 15 largest healthcare law firms nationwide by Modern Healthcare

Visit the Holland & Knight Healthcare Blog for timely updates on healthcare fraud and abuse, technology, health plans, facility operations, long-term care, life sciences and public policy.

Case Studies

Multimedia

Shannon Hartsfield & Eddie Williams Discuss Patient Access to Medical Data
Podcast: Shannon Hartsfield & Eddie Williams Discuss Patient Access to Medical Data
Providing Accessible Healthcare for All in a Digital Age
Podcast: Providing Accessible Healthcare for All in a Digital Age
Discussing Sickle Cell Research and Care with Dr. James Taylor VI, MD
Podcast - Discussing Sickle Cell Research and Care with Dr. James Taylor VI, MD
Discussing the Mission of Black Women's Health Imperative with CEO Linda Goler Blount
Podcast - Discussing the Mission of Black Women's Health Imperative with CEO Linda Goler Blount
SickleCell_Still
Podcast - Talking Sickle Cell Trait with NFL Wide Receiver Ty Montgomery and Dr. Anjulika Chawla, MD, FAAP
Podcast: Discussing HIPAA with Shannon Hartsfield and Eddie Williams
Podcast: Discussing HIPAA with Shannon Hartsfield and Eddie Williams
Podcast - We Can Do Hard Things: Educate, Advocate & Inspire
Podcast - "We Can Do Hard Things: Educate, Advocate & Inspire"
Podcast: Discussing Legislation with Kimberly Case and Beth Vecchioli
Podcast: Discussing Legislation with Kimberly Case and Beth Vecchioli
Capital Conversations, Episode 3
Podcast: Discussing Healthcare with Shannon Hartsfield and Eddie Williams
"Chirping" on Sickle Cell: A Discussion with Bluebird Bio and Dr. Anjulika Chawla, M.D., FAAP
Podcast - "Chirping" on Sickle Cell: A Discussion with bluebird bio and Dr. Anjulika Chawla, M.D., FAAP
Discussing State Insurance Regulation with Beth Vecchioli
Podcast: Discussing State Insurance Regulation with Beth Vecchioli
Icon of a smartphone with healthcare related icons surrounding
Cures 2.0 Next Steps
FDA's Oversight of Digital Health Products and Medical Software
FDA's Oversight of Digital Health Products and Medical Software
Nathan Adams COVID-19 Vaccination Webinar
Can Your Organization Show Preference for Vaccinated Customers and Clients?
Podcast: First 100 Days of the Biden Administration, Episode 4 - COVID-19 Vaccines and HHS Updates
Podcast: COVID-19 Vaccines and HHS Updates
Insights and Outlook on Community Project Funding Webinar
Insights and Outlook on Community Project (Earmark) Funding
sound waves
Rich Gold on the American Rescue Plan, the Return of Earmarks, & More
U.S. & Israeli Innovations in the Life Sciences: Part 2
U.S. & Israeli Innovations in the Life Sciences: Part 2
First 100 Days Title Slide
Podcast: Healthcare Priorities and Landscape
Eric Crusius, Partner at Holland & Knight, is interviewed on Government Matters
Using the Defense Production Act for Vaccine Distribution
Coffee & Conversation
Coffee & Conversation - Building an Effective Compliance Program: Key Considerations for the Pharmaceutical Industry
2020 Post-Election Briefing with Bloomberg Government
2020 Post-Election Briefing with Bloomberg Government
Pre-Election Webinar Series: Healthcare recording still
Election 2020: Potential Impacts Series - Healthcare & Life Sciences
sound waves
HIPAA and Digital Health Mistakes: An Interview With Shannon Hartsfield
When HHS Knocks at the Door still
When HHS Knocks at the Door — Preparing for Provider Relief Fund Attestation Defense
Bosco_Elliott_Robertson_Media_Still
Understanding the Coronavirus Emergency Loan Program for Small Businesses
sound waves
How Cannabis-Tech Transformed Israel from a Start-Up Nation into an AgTech Nation
Avoiding HIPAA Headaches and Hassles
Avoiding HIPAA Headaches and Hassles
Midterm Post Election Briefing 2018
Midterm Post Election Briefing 2018
A Preview of the FBA's "Qui Tam 2019" Conference
A Preview of the FBA's "Qui Tam 2019" Conference
What the FDA's New Framework Means for Regenerative Therapies
What the FDA's New Framework Means for Regenerative Therapies
Straight from the Cutter’s Mouth: A Retina Podcast
Straight from the Cutter’s Mouth: A Retina Podcast
Stem Cell Treatment Promised by Clinics, but Has It Been Proven?
Stem Cell Treatment Promised by Clinics, but Has It Been Proven?
CMS, FDA and the “Parallel Review Process”
CMS, FDA and the “Parallel Review Process”

Publications

Upcoming Events

News and Headlines